Day: August 29, 2023
TRAVERSE CITY, Mich., Aug. 29, 2023 (GLOBE NEWSWIRE) — MachTen, Inc. (“MACT”) (OTC: MACT) today reported its operating results for the quarter ended June 30, 2023.
Financial Highlights(In thousands)
Three Months Ended
June 30,2023
June 30,2022
Regulated revenue
$
3,035
$
3,069
Non-regulated revenue
$
950
$
885
Operating profit
$
1,435
$
1,478
Net income
$
1,060
$
1,053
Revenue Regulated revenue declined to $3.04 million in the 2nd quarter of 2023 from $3.07 million in the same period last year, primarily attributable to the elimination of a Michigan Universal Service Fund (USF) program. As a result of this program’s elimination in mid-2022, intrastate access and USF revenue declined to $18,000 in the 2nd quarter, compared to $91,000 in the prior...
SHARC Energy Announces Q2 2023 Financial Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
VANCOUVER, British Columbia, Aug. 29, 2023 (GLOBE NEWSWIRE) — SHARC International Systems Inc. (CSE: SHRC) (FSE: IWIA) (OTCQB: INTWF) (“SHARC Energy” or the “Company”) announces it has filed financial results for the six months ended June 30, 2023. All figures are in Canadian Dollars and in accordance with IFRS unless otherwise stated.
Second Quarter and Year-to-date Financial Highlights:As of August 29, 2023, the Company has a Sales Pipeline1 of 16.7 million (M) and Sales Order Backlog2 of $1.3M. This represents minor growth in Sales Pipeline and a 20% increase in Sales Order Backlog. The increase in Sales Order Backlog is due to the completion of submittals and receiving purchase orders on deals previously disclosed in Sales Pipeline.
Working capital of $4.2M, which includes $3.1M of cash, as of June 30, 2023. The...
Rakovina Therapeutics Inc. Announces Q2 2023 Financial Results and Provides Corporate Update
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
VANCOUVER, British Columbia, Aug. 29, 2023 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”), a biopharmaceutical company dedicated to improving the lives of cancer patients through development of novel DNA-damage response inhibitor therapeutics, announced financial results for the quarter ended June 30, 2023, and provided a corporate update.
Corporate highlights during the past quarter included:The publication of a paper in the Journal of Clinical Oncology describing pre-clinical data for our lead pre-clinical candidate, kt-3283, demonstrating kt-3283’s potential to treat cancers that are resistant to first-generation PARP inhibitors. We believe these data support the potential to address unmet medical needs in the treatment of a range of treatment-resistant cancers including Ewing sarcoma, breast cancer,...
OceanPal Inc. Becomes Strategic Partner In Two 6,600dwt Methanol-Ready Chemical Tanker Newbuildings
Written by Customer Service on . Posted in Public Companies.
ATHENS, Greece, Aug. 29, 2023 (GLOBE NEWSWIRE) — OceanPal Inc. (NASDAQ: OP) (the “Company”), a global shipping company specializing in the ownership of vessels, announced that the Company today agreed to become a strategic partner and invest in a Norwegian entity, RFSea Infrastructure II AS, that will construct, at Wuhu Shipyard Co., Ltd. (China), under two separate newbuilding contracts, two 6,600 dwt methanol-ready, stainless steel chemical tankers with expected deliveries during the fourth quarter of 2025 and the first quarter of 2026, respectively. The transaction remains subject to the satisfaction of customary closing conditions.
The Company is partnering with a private London-based alternative investment and commercial management firm focusing on the maritime industry and other partners and investors. Fearnley Securities...
Certara Simcyp™ Group Awarded Two New Grants from US FDA
Written by Customer Service on . Posted in Public Companies.
Programs focus on use of physiologically-based pharmacokinetic (PBPK) modeling for demonstrating virtual bioequivalence and predicting drug absorption of topical formulations
PRINCETON, N.J., Aug. 29, 2023 (GLOBE NEWSWIRE) — Certara (Nasdaq: CERT), a global leader in biosimulation, today announced that the Simcyp group has been awarded two new grants from the U.S. Food and Drug Administration (FDA) to expand its predictive models for assessing drug virtual bioequivalence (VBE) and to create a formulation toolbox for topically applied drugs. These capabilities will help enable safer, faster and more cost-effective product development of both complex generics and novel drugs.
“We are proud to collaborate with the FDA in developing innovative model-informed approaches for accelerating drug development of complex generic and innovator...
Rumpl Partners with Nogin To Supercharge D2C Growth
Written by Customer Service on . Posted in Public Companies.
Rumpl to leverage Nogin’s Commerce-as-a-Service solution to drive rapid direct-to-consumer growth and amplify brand reach
TUSTIN, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) — Nogin (Nasdaq: NOGN), a pioneer in Commerce-as-a-Service (“CaaS”), today announced that Rumpl, the category leader in technical blankets, has chosen Nogin’s Intelligent Commerce technology and services to grow its direct-to-consumer (D2C) business. Nogin’s enterprise-class technology and deep ecommerce expertise will drive accelerated growth for Rumpl as it continues to redefine the category of blankets and technical comfort products.
Founded on a surf and ski trip through California, Rumpl specializes in producing sustainable, high-performance outdoor blankets using innovative materials and designs. Delivering a blend of functionality and style, Rumpl’s...
CMS grants reimbursement code for the Polarean XENOVIEW™ MRI Technology
Written by Customer Service on . Posted in Public Companies.
The code is effective as of October 1, 2023
Durham, NC, Aug. 29, 2023 (GLOBE NEWSWIRE) —
Polarean (AIM: POLX), a commercial-stage medical device leader in advanced MRI scanning of the lungs, announces that the Centers for Medicare & Medicaid Services (CMS) has established a new reimbursement code for the Polarean XENOVIEW™ (xenon Xe 129, hyperpolarized) technology, effective October 1, 2023.
The code (C9791) enables healthcare providers a path to bill for “magnetic resonance imaging with inhaled hyperpolarized xenon-129 contrast agent, chest, including preparation and administration of agent”. This was announced as part of the release of the October 2023 Healthcare Common Procedure Coding System (HCPCS) code set. The payment level associated with the XENOVIEW™ MRI code is yet to be announced and is expected...
GOGL – Q2 2023 Presentation
Written by Customer Service on . Posted in Public Companies.
Please find enclosed the presentation of Golden Ocean Group Limited’s second quarter 2023 results for today’s webcast / conference call at 15:00 CEST.
Attend by Webcast:
Use the follow link prior to the webcast:
GOGL Q2 2023 Webcast
Attend by Conference Call:
Participants will need to register online prior to the conference call via the link below. Dial-in details will be available when registered.
GOGL Q2 2023 Conference Call
A Q&A session will be held after the conference call/webcast. Information on how to submit questions will be given at the beginning of the session.
The presentation material which will be used in the teleconference/webcast can be downloaded on www.goldenocean.bm and replay details will also be available at this website.
This information is subject to the disclosure requirements pursuant to Section 5-12 the...
StepStone Group to Present at the Barclays Global Financial Services Conference
Written by Customer Service on . Posted in Public Companies.
NEW YORK, Aug. 29, 2023 (GLOBE NEWSWIRE) — StepStone Group Inc. (Nasdaq: STEP) today announced that Scott Hart, CEO, and Mike McCabe, Head of Strategy, are scheduled to present at the Barclays Global Financial Services Conference on Tuesday, September 12, 2023 at 2:45 pm ET. A live webcast and replay will be accessible through the StepStone website at https://shareholders.stepstonegroup.com.
About StepStone
StepStone Group Inc. (Nasdaq: STEP) is a global private markets investment firm focused on providing customized investment solutions and advisory, data and administrative services to its clients. As of June 30, 2023, StepStone was responsible for approximately $640 billion of total capital, including $143 billion of assets under management. StepStone’s clients include some of the world’s largest public and private...
BIGG Digital Assets Inc. Portfolio Company TerraZero Technologies to Launch New Subscription-Based Platform Intraverse PRO
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, Aug. 29, 2023 (GLOBE NEWSWIRE) — BIGG Digital Assets Inc. (“BIGG” or the “Company”) (CSE: BIGG; OTCQX: BBKCF; WKN: A2PS9W), owner of Netcoins, Blockchain Intelligence Group, an investor in TerraZero Technologies Inc. (“TerraZero”), a vertically integrated Metaverse development group and leading web3 technology company specializing in helping brands create immersive experiences, announces their plans to release Intraverse PRO. This addition to the TerraZero portfolio sets the stage for unparalleled omni-channel connectivity, solidifying the company’s commitment to delivering cutting-edge solutions for modern businesses, now with a significant focus on artists, creators and SMBs with Intraverse PRO.
“We are thrilled to usher in a new era of immersive virtual experiences...